发明名称 Activated vitronectin as a marker of angiogenesis detected with phage antibodies
摘要 <p>The present invention provides a method for producing antibody fragments that discriminate between native and activated vitronectin, which can be used as markers of angiogenesis. Also provided are antibodies and peptides comprising said fragments, and therapeutic methods, particularly related to targeting for antibody-mediated anti-vascular cancer therapy and inhibiting the adhesion and migration of tumor-endothelial cells and platelets.</p>
申请公布号 EP1130099(A1) 申请公布日期 2001.09.05
申请号 EP20010200711 申请日期 2001.02.26
申请人 CRUCELL HOLLAND B.V. 发明人 VOEST, EMILE EUGENE;BLOEMENDAL, HENRI JOHAN;DE BOER, HENRIETTE CHRISTINE;GEBBINK, MARTIJN FRANS BEN GERARD;LOGTENBERG, TON
分类号 A61P35/00;C07K14/78;C07K16/18;C12N15/12;C12N15/13;(IPC1-7):C12N15/13;A61K39/395;G01N33/68;G01N33/577;C07K19/00 主分类号 A61P35/00
代理机构 代理人
主权项
地址